Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit
Send a message to the White House demanding bold action to stop COVID-19 and end the pandemic! Take Action
Undemocratic WTO Processes Produce Shameful Result on Intellectual Property and Covid at 12th WTO Ministerial
Supplement to the Petition to the FDA to Ban Olmesartan-Containing Hypertension Medications February 1, 2018